{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000343.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000343.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T a-syn gene mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004989"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Familial PD case with A53T mutation",
        "Description": "A case of familial PD with the A53T a-syn gene mutation was studied."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000343.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Insoluble filamentous a-syn lesions were detected in almost all brain regions. Accumulation of insoluble nitrated a-syn was observed. Filamentous insoluble tau protein also accumulated in some regions."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Absence of insoluble filamentous a-syn lesions and nitrated a-syn accumulation",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of insoluble filamentous a-syn lesions and nitrated a-syn accumulation",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro fibril formation assay",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "A53T-mutant and wild-type a-syn proteins",
        "Description": "In vitro experiments using A53T-mutant and wild-type a-syn proteins."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000343.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "The A53T mutation accelerated fibril formation and induced cross-seeding with tau protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fibril formation rate comparable to wild-type a-syn",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Fibril formation rate significantly higher than wild-type a-syn",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}